Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Conference Highlights ADA
Conference Highlights ADA
Look AHEAD Trial: Intensive Lifestyle Intervention Can Achieve Sustained Weight Loss in Type 2 Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Anti-VEGF Antibody Injections Improve Vision in Diabetic Macular Edema
Wayne Kuznar
Read More
Conference Highlights ADA
Concern Raised About Ocular Risks of Diabetes Treatments
Alice Goodman
Read More
Conference Highlights ADA
Artificial Pancreas Passes Test in Patients with Type 1 Diabetes
Wayne Kuznar
Read More
Conference Highlights ADA
Intensive versus Standard Blood Pressure Control of No Benefit in Quality of Life for Patients with Type 2 Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Medical Food Improves Symptoms of Diabetic Neuropathy
Wayne Kuznar
Read More
Conference Highlights ADA
HbA1c Screening Fails to Identify Many Patients with Diabetes and Prediabetes
Alice Goodman
Read More
Conference Highlights ADA
Education, Counseling Associated with Improved Clinical Outcomes in Type 2 Diabetes
Wayne Kuznar
Read More
Conference Highlights ADA
Ultra-Long-Acting Insulin Degludec Noninferior to Insulin Glargine with Less Hypoglycemia in Type 1 and Type 2 Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Treatment Satisfaction Highest for Diabetic Patients Taking Only Oral Medications
Wayne Kuznar
Read More
1
2
3
Page 1 of 3
Results 1 - 10 of 22